Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 31/5/2020
SIETES contiene 93020 citas

 
 
 1 a 16 de 16 
Presentar resultados
Seleccionar todas
2. Cita con resumen
Liu Y-Y, Wang Y, Walsh TR, Yi L-X, Spencer J, Doi Y, Tian G, Dong B, Huang X, Yu L-F, Gu D, Ren H, Chen X, Lv L, He D, Zhou H, Liang Z, Liu J-H, Shen J. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. The Lancet Infectious Diseases 2015:18 de noviembre. [Ref.ID 99647]
3. Cita con resumen
Hosseinjani H, Moghaddas A, Khalili H. N-acetylcysteine for the prevention of non-constrast media agent-induced kidney injury: from preclinical data to clinical evidence. Eur J Clin Pharmacol 2013;69:1375-90. [Ref.ID 95850]
4. Cita con resumen
Ramírez E, Rossignoli T, Campos AJ, Muñoz R, Zegarra C, Tong H, Medrano N, Borobia AM, Carcas AJ, Frías J. Drug-induced life-threatening potassium disturbances detected by a pharmacovigilance program from laboratory signals . Eur J Clin Pharmacol 2013;69:97-110. [Ref.ID 94842]
5. Cita con resumen
Anónimo. Colistiméthate poudre à inhaler. Pas mieux que la tobramycine. Prescrire 2013;33:12. [Ref.ID 94671]
6. Cita con resumen
Florescu DF, Qiu F, McCartan MA, Mindru C, Fey PD, Kalil AC. What Is the Efficacy and Safety of colistin for the treatment of ventilator-associated pneumonia? A systematic review and meta-regression •. Clin Infect Dis 2012;54:670-80. [Ref.ID 92241]
7.
Miselli M. Colistimetato. Informazioni sui Farmaci 2011;35:25-7. [Ref.ID 91089]
8.Enlace a cita original Cita con resumen
Grill MF, Maganti RK. Neurotoxic effects associated with antibiotic use: management considerations. Br J Clin Pharmacol 2011;72:381-93. [Ref.ID 90989]
9.
Anónimo. Aztréonam inhalé. 3e antibiotique inhalé dans la mucoviscidose. Drug Ther Bull 2007;45:733. [Ref.ID 89213]
10. Cita con resumen
Anónimo. Insuffisances rénales d'origine médicamenteuse. Prescrire 2009;29:506-10. [Ref.ID 86213]
11. Cita con resumen
Falagas ME, Michalopoulos A. Polymyxins: old antibiotics are back. Lancet 2006;367:633-4. [Ref.ID 76242]
12.
Sermet-Gaudelus I, Le Cocguic Y, Ferroni A, Clairicia M, Barthe J, Delaunay JP, Brousse V, Lenoir G. Nebulized antibiotics in cystic fibrosis. Pediatr Drugs 2002;4:455-67. [Ref.ID 62722]
13.
Reed M D, Stern RC, O'Riordan MA, Blumer JL. The pharmacokinetics of colistin in patients with cystic fibrosis. J Clin Pharmacol 2001;41:645-54. [Ref.ID 57429]
14.
Revuelta Mínguez Mª P, Panadero Esteban MªI, Pérez-Landeiro A, Navarro Aznárez H, Carcelén Andrés J, Mendaza Beltrán M. Estudio retrospectivo de pacientes con fibrosis quística. Evolución del tratamiento después de cinco años. Aten Farmaceutica 2001;3:23-9. [Ref.ID 55782]
15.
Evans ME, Feola DJ, Rapp R P. Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria. Ann Pharmacother 1999;33:960-7. [Ref.ID 47028]
16.
Zamparutti P. La nébulisation pour l'administration de médicaments par voie respiratoire. Bulletin d'Information du Médicament et de Pharmacovigilance CRIM Rennes 1997;70:1-3. [Ref.ID 32282]
Seleccionar todas
 
 1 a 16 de 16